Synthesis and antidepressant activity of 5-phenyl-2-(2-propynylamino)-2-oxazolin-4-one and derivatives.
D000284:Administration, Oral; D000480:Alkynes / Q000008:administration & dosage / Q000138:chemical synthesis / Q000494:pharmacology / Q000633:toxicity; D000818:Animals; D000928:Antidepressive Agents / Q000008:administration & dosage / Q000138:chemical synthesis* / Q000494:pharmacology / Q000633:toxicity; D001522:Behavior, Animal / Q000187:drug effects; D001923:Brain Chemistry / Q000187:drug effects; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004298:Dopamine / Q000032:analysis; D004357:Drug Synergism; D007928:Lethal Dose 50; D051379:Mice; D009638:Norepinephrine / Q000032:analysis; D010389:Pemoline / Q000008:administration & dosage / Q000138:chemical synthesis* / Q000494:pharmacology / Q000633:toxicity; D012701:Serotonin / Q000032:analysis; D013329:Structure-Activity Relationship
D000480:Alkynes; D000928:Antidepressive Agents; D012701:Serotonin; D004295:Dihydroxyphenylalanine; D010389:Pemoline; D004298:Dopamine; D009638:Norepinephrine